Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $118,011
Award facts
- Contract value 100% obligated
- $118,010.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $118,010.76 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on January 26, 2026, with an ultimate completion date of January 27, 2026, carries no set-aside designation and represents a competitive award under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The company will supply pharmaceutical products and medical consumables to support federal healthcare operations, drawing from its extensive inventory of branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals.
This delivery order operates under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract designated SPE2DR, which was established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative—a $30.3 billion acquisition strategy designed to consolidate pharmaceutical supply chains for the Department of Defense. The parent IDC, awarded in November 2025 with a $499,999,999 ceiling value and a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor authorized to fulfill recurring pharmaceutical and medical supply needs for military healthcare facilities worldwide. The contractor performs the work at its facility in Park Ridge, Illinois, with no subcontractor relationships identified in the award documentation.
Quick answers
Who was awarded contract SPE2DU26FEMRL?
SPE2DU26FEMRL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DU26FEMRL worth?
The government has obligated $118,011 on SPE2DU26FEMRL.
Is contract SPE2DU26FEMRL an order under another contract?
Yes. SPE2DU26FEMRL is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRL competed?
The extent of competition for SPE2DU26FEMRL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award